232 related articles for article (PubMed ID: 17092912)
1. Discovering severe acute respiratory syndrome coronavirus 3CL protease inhibitors: virtual screening, surface plasmon resonance, and fluorescence resonance energy transfer assays.
Chen L; Chen S; Gui C; Shen J; Shen X; Jiang H
J Biomol Screen; 2006 Dec; 11(8):915-21. PubMed ID: 17092912
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.
Tsai KC; Chen SY; Liang PH; Lu IL; Mahindroo N; Hsieh HP; Chao YS; Liu L; Liu D; Lien W; Lin TH; Wu SY
J Med Chem; 2006 Jun; 49(12):3485-95. PubMed ID: 16759091
[TBL] [Abstract][Full Text] [Related]
3. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.
Ryu YB; Jeong HJ; Kim JH; Kim YM; Park JY; Kim D; Nguyen TT; Park SJ; Chang JS; Park KH; Rho MC; Lee WS
Bioorg Med Chem; 2010 Nov; 18(22):7940-7. PubMed ID: 20934345
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
Chen S; Chen LL; Luo HB; Sun T; Chen J; Ye F; Cai JH; Shen JK; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Jan; 26(1):99-106. PubMed ID: 15659121
[TBL] [Abstract][Full Text] [Related]
5. Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits.
Mukherjee P; Desai P; Ross L; White EL; Avery MA
Bioorg Med Chem; 2008 Apr; 16(7):4138-49. PubMed ID: 18343121
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors.
Yang Q; Chen L; He X; Gao Z; Shen X; Bai D
Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1400-5. PubMed ID: 18827378
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.
Chen LR; Wang YC; Lin YW; Chou SY; Chen SF; Liu LT; Wu YT; Kuo CJ; Chen TS; Juang SH
Bioorg Med Chem Lett; 2005 Jun; 15(12):3058-62. PubMed ID: 15896959
[TBL] [Abstract][Full Text] [Related]
8. Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease.
Liu YC; Huang V; Chao TC; Hsiao CD; Lin A; Chang MF; Chow LP
Biochem Biophys Res Commun; 2005 Jul; 333(1):194-9. PubMed ID: 15950190
[TBL] [Abstract][Full Text] [Related]
9. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease.
Konno H; Wakabayashi M; Takanuma D; Saito Y; Akaji K
Bioorg Med Chem; 2016 Mar; 24(6):1241-54. PubMed ID: 26879854
[TBL] [Abstract][Full Text] [Related]
11. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation.
Nguyen TT; Ryu HJ; Lee SH; Hwang S; Breton V; Rhee JH; Kim D
Bioorg Med Chem Lett; 2011 May; 21(10):3088-91. PubMed ID: 21470860
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease.
Shao YM; Yang WB; Kuo TH; Tsai KC; Lin CH; Yang AS; Liang PH; Wong CH
Bioorg Med Chem; 2008 Apr; 16(8):4652-60. PubMed ID: 18329272
[TBL] [Abstract][Full Text] [Related]
14. Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL
Ma L; Li Q; Xie Y; Jianyuan Zhao ; Yi D; Guo S; Guo F; Wang J; Yang L; Cen S
Antiviral Res; 2022 Nov; 207():105419. PubMed ID: 36155070
[TBL] [Abstract][Full Text] [Related]
15. Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features.
Chen L; Li J; Luo C; Liu H; Xu W; Chen G; Liew OW; Zhu W; Puah CM; Shen X; Jiang H
Bioorg Med Chem; 2006 Dec; 14(24):8295-306. PubMed ID: 17046271
[TBL] [Abstract][Full Text] [Related]
16. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays.
Kuang WF; Chow LP; Wu MH; Hwang LH
Biochem Biophys Res Commun; 2005 Jun; 331(4):1554-9. PubMed ID: 15883050
[TBL] [Abstract][Full Text] [Related]
17. An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
Pillaiyar T; Manickam M; Namasivayam V; Hayashi Y; Jung SH
J Med Chem; 2016 Jul; 59(14):6595-628. PubMed ID: 26878082
[TBL] [Abstract][Full Text] [Related]
18. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.
Hsu JT; Kuo CJ; Hsieh HP; Wang YC; Huang KK; Lin CP; Huang PF; Chen X; Liang PH
FEBS Lett; 2004 Sep; 574(1-3):116-20. PubMed ID: 15358550
[TBL] [Abstract][Full Text] [Related]
20. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
